Please login to the form below

Not currently logged in
Email:
Password:

Valeant adds Robert Hale to board of directors

And Jeffrey Ubben resigns from the board
Valeant Robert Hale

Valeant has added Robert Hale, a partner at ValueAct Capital, to its board of directors.

Hale will be the fourth partner of ValueAct Capital, which holds approximately 4% of Valeant's outstanding stock, to serve on the Valeant board.

ValueAct Capital has been a shareholder in Valeant since 2006 and as a partner there Hale has worked closely with the board and management team since January 2011.

He said: “It's an exciting time for Valeant as the company positions itself for long-term growth and leadership in the pharmaceuticals and medical products industry.”

Meanwhile, Jeffrey Ubben, CEO and CIO of ValueAct Capital has resigned from the board.

He said: “I have had a wonderful experience serving as director of Valeant. While I no longer serve as a director, I look forward to working with Mike Pearson and the Valeant team as an interested shareholder on an on-going basis.”

Michael Pearson, chairman and CEO of Valeant, said: “We are delighted that we will continue to have board representation from ValueAct Capital.

“We have gotten to know Rob well over the past five years and are glad that he now serves as a director. Rob's strategic and financial expertise will add a valuable perspective to our board.”

Hale, prior to his current position, was principal of The Parthenon Group working at both their Boston and Mumbai offices.

27th August 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics